Asia Pacific Vascular Graft Market was valued at USD 270.84 Million in the year 2021. Asia Pacific Vascular Graft Market is further estimated to grow at a CAGR of 7.33% from 2022 to 2030 it will reach USD 507.47 Million by the year 2030. The Chinese region holds the highest market share in 2021 and the India region is considered as the fastest growing market in the forecasted period. At a country level, China, India and Japan are projected to grow strongly in the coming years due to increase in vascular diseases, such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders as well as increase in number of hospitals and surgery centers, which boost the diagnosis and treatment of diseases. The Asia Pacific Vascular Graft Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section. On the basis of Type, the market is divided as Hemodialysis Access Graft, and Peripheral Vascular Graft. In which Peripheral Vascular Graft holds the highest market share due to increasing demand. Market player analysis of major companies such as B. Braun Melsungen AG, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. KG, Medtronic plc, Terumo Corporation, and W. L. Gore & Associates, Inc.
Scope:
Report Data
Market
Forecast 2022
XX million/billion (2022-2032)
CAGR 2022 - 2032
%
Analysis Period
2022 - 2032
Base Year
2021
Forecast Data
2022 - 2032
Segments Covered
By Type, By Application, And by Regions
Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
1 INTRODUCTION 1.1 OBJECTIVES 1.2 MARKET DEFINITION 1.2.1 MARKET SCOPE 1.3 RESEARCH METHODOLOGY 1.3.1 SECONDARY DATA 1.3.2 PRIMARY DATA 1.3.3 MARKET SIZE ESTIMATION 1.3.4 BOTTOM-UP APPROACH 1.3.5 TOP-DOWN APPROACH 1.3.6 MARKET ASSUMPTION 1.4 STAKEHOLDERS 1.5 CURRENCY 1.6 YEARS CONSIDERED 1.7 LIMITATION 2 EXECUTIVE SUMMARY 3 MARKET OUTLOOK 3.1 INTRODUCTION 3.2 DROC MATRIX 3.3 MARKET CHALLENGES 3.4 COST STRUCTURE ANALYSIS 3.5 VALUE CHAIN ANALYSIS 3.6 COVID-19 IMPACT ANALYSIS 4 INDUSTRY TRENDS 4.1 INTRODUCTION 4.2 MARKET OPPORTUNITY 4.2.1 APPLICATION IN KIDNEY FAILURE IS EXPECTED TO REGISTER ROBUST GROWTH 4.2.2 EMERGING MARKETS 4.2.3 INCREASING NEED FOR HEMODIALYSIS 4.3 NEW TECHNOLOGIES AND DEVELOPMENTS 4.3.1 TISSUE-ENGINEERED VASCULAR GRAFTS: EMERGING TRENDS AND TECHNOLOGIES 4.3.2 VASCULAR GRAFTS FROM STEM CELLS 4.3.3 ADVANCING VASCULAR THERAPIES BY MINT (MINIMALLY INVASIVE NEW TECHNOLOGIES) 4.3.4 NANOGRAFT: A NOVEL SMALL DIAMETER NANOTEXTILE ARTERIAL GRAFT 4.3.5 VASCUGRAFT PTFE DEVELOPED BY B. BRAUN 4.4 PORTER’S FIVE FORCES MODEL 4.4.1 DEGREE OF COMPETITION 4.4.2 BARGAINING POWER OF BUYERS 4.4.3 BARGAINING POWER OF SUPPLIERS 4.4.4 THREAT FROM SUBSTITUTES 4.4.5 THREAT FROM NEW ENTRANTS 5 VASCULAR GRAFT TYPE ANALYSIS 5.1 INTRODUCTION 5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2021 5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 5.4 Y-O-Y GROWTH TREND ANALYSIS 6 ASIA PACIFIC VASCULAR GRAFT REGIONAL ANALYSIS 6.1 INTRODUCTION 6.2 ASIA-PACIFIC 6.2.1 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2015–2030 6.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2015–2030 6.2.3 Y-O-Y GROWTH TREND ANALYSIS 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 South Korea 6.2.3.4 India 6.2.3.5 Malaysia 6.2.3.6 Philippines 6.2.3.7 Australia 6.2.3.8 Thailand 7 COMPANY PROFILE 7.1 B. BRAUN MELSUNGEN AG 7.1.1 BUSINESS OVERVIEW 7.1.2 FINANCIAL OVERVIEW (2021) 7.1.3 PRODUCT PORTFOLIO 7.1.4 RECENT DEVELOPMENTS 7.2 BD (C. R. BARD, INC. AQUIRED IN 2017) 7.2.1 BUSINESS OVERVIEW 7.2.2 FINANCIAL OVERVIEW (2021) 7.2.3 PRODUCT PORTFOLIO 7.2.4 RECENT DEVELOPMENTS 7.3 CARDINAL HEALTH INC. 7.3.1 BUSINESS OVERVIEW 7.3.2 FINANCIAL OVERVIEW (2021) 7.3.3 PRODUCT PORTFOLIO 7.3.4 RECENT DEVELOPMENTS 7.4 COOK MEDICAL INC 7.4.1 BUSINESS OVERVIEW 7.4.2 FINANCIAL OVERVIEW (2021) 7.4.3 PRODUCT PORTFOLIO 7.4.4 RECENT DEVELOPMENTS 7.5 ENDOLOGIX INC. 7.5.1 BUSINESS OVERVIEW 7.5.2 FINANCIAL OVERVIEW (2021) 7.5.3 PRODUCT PORTFOLIO 7.5.4 RECENT DEVELOPMENTS 7.6 LEMAITRE VASCULAR, INC. 7.6.1 BUSINESS OVERVIEW 7.6.2 FINANCIAL OVERVIEW (2021) 7.6.3 PRODUCT PORTFOLIO 7.6.4 RECENT DEVELOPMENTS 7.7 GETINGE (AQQUIRED MAQUET HOLDING B.V. & CO. KG IN 2000) 7.7.1 BUSINESS OVERVIEW 7.7.2 FINANCIAL OVERVIEW (2021) 7.7.3 PRODUCT PORTFOLIO 7.7.4 RECENT DEVELOPMENTS 7.8 MEDTRONIC PLC 7.8.1 BUSINESS OVERVIEW 7.8.2 FINANCIAL OVERVIEW (2021) 7.8.3 PRODUCT PORTFOLIO 7.8.4 RECENT DEVELOPMENTS 7.9 TERUMO CORPORATION 7.9.1 BUSINESS OVERVIEW 7.9.2 FINANCIAL OVERVIEW (2021) 7.9.3 PRODUCT PORTFOLIO 7.9.4 RECENT DEVELOPMENTS 7.10 W. L. GORE & ASSOCIATES, INC. 7.10.1 BUSINESS OVERVIEW 7.10.2 FINANCIAL OVERVIEW (2021) 7.10.3 PRODUCT PORTFOLIO 7.10.4 RECENT DEVELOPMENTS 7.11 CARDIATIS S.A. 7.11.1 BUSINESS OVERVIEW 7.11.2 FINANCIAL OVERVIEW (2021) 7.11.3 PRODUCT PORTFOLIO 7.11.4 RECENT DEVELOPMENTS 7.12 JOTEC GMBH 7.12.1 BUSINESS OVERVIEW 7.12.2 FINANCIAL OVERVIEW (2021) 7.12.3 PRODUCT PORTFOLIO 7.12.4 RECENT DEVELOPMENTS 7.13 LOMBARD MEDICAL, INC. 7.13.1 BUSINESS OVERVIEW 7.13.2 FINANCIAL OVERVIEW (2021) 7.13.3 PRODUCT PORTFOLIO 7.13.4 RECENT DEVELOPMENTS 7.14 NANO ENDOLUMINAL. 7.14.1 BUSINESS OVERVIEW 7.14.2 FINANCIAL OVERVIEW (2021) 7.14.3 PRODUCT PORTFOLIO 7.14.4 RECENT DEVELOPMENTS 7.15 SHANGHAI SUOKANG MEDICAL IMPLANTS CO., LTD 7.15.1 BUSINESS OVERVIEW 7.15.2 FINANCIAL OVERVIEW (2021) 7.15.3 PRODUCT PORTFOLIO 7.15.4 RECENT DEVELOPMENTS 7.16 PRODUCT OVERVIEW 7.17 DISTRIBUTOR LIST (BEST EFFORT METHOD) 8 ABOUT US
TABLE 1 ASIA PACIFIC VASCULAR GRAFT REGIONAL ANALYSIS, 2015–2020 (USD MILLION) TABLE 2 ASIA PACIFIC VASCULAR GRAFT MARKET, 2021–2030, (USD MILLION) TABLE 3 VASCULAR GRAFT CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 4 ASIA PACIFIC VASCULAR GRAFT HISTORICAL MARKET TYPE ANALYSIS, 2015-2021, (USD MILLION) TABLE 5 VASCULAR GRAFT CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 6 ASIA PACIFIC VASCULAR GRAFT REGIONAL ANALYSIS, 2015–2020 (USD MILLION) TABLE 7 ASIA PACIFIC VASCULAR GRAFT MARKET, 2021–2030, (USD MILLION) TABLE 8 ASIA PACIFIC VASCULAR GRAFT REGIONAL ANALYSIS, 2015–2020 (‘000 UNITS) TABLE 9 ASIA PACIFIC VASCULAR GRAFT MARKET, 2021–2030, (‘000 UNITS) TABLE 10 ASIA PACIFIC VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 11 ASIA PACIFIC VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 12 CHINA VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 13 HONGKONG VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 14 TAIWAN VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 15 JAPAN VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 16 KOREA VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 17 INDIA VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 18 MALAYSIA VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 19 PHILIPPINES VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 20 AUSTRALIA VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION) TABLE 21 THAILAND VASCULAR GRAFT MARKET CURRENT AND FUTURE SOLUTION TYPE ANALYSIS, 2015–2030 (USD MILLION)
Frequently Asked Questions
What is the future market value of the ?
The current market value for is expected USD XX million/billion by 2022.
What is the CAGR of the Market?
The is to grow at a CAGR of 5.3% during the forecast by 2032.
What is the Market segment?
On the basis of type, the is segmented into Types.